COVID Tech Offers Hope for Melanoma Patients: Fewer Cases Reported

COVID-19 Technologies Offer New Hope for‌ Melanoma Patients Recent advancements stemming from ⁤research accelerated by the COVID-19‍ pandemic⁤ are showing promising results⁢ in the ‍fight against melanoma, the ⁣deadliest form of skin cancer. ​Specifically, technologies developed for​ mRNA vaccine creation and rapid diagnostics are being repurposed to enhance immunotherapy effectiveness and improve early detection of … Read more

>Multiple Myeloma: J&J Treatment Shows 83.4% Progression-Free at 3 Years

2026-01-19 12:50:00 Mieloma múltiple: tratamiento de J&J muestran 83,4% de pacientes libres de progresión a 3 años Johnson & Johnson pidió a la Agencia Europea de Medicamentos (EMA) aprobar la combinación de Tecvayli (teclistamab) y Darzalex Faspro (daratumumab + hialuronidasa-fihj) como tratamiento de segunda línea para mieloma múltiple refractario o recaído, apoyada en un ensayo … Read more